New Tech Targets Epilepsy With Lasers, Robots

New Tech Targets Epilepsy With Lasers, Robots

Up next

When batteries get a facelift, so does renewable energy

For years, renewable energy companies have faced a problem: How to store the mass amounts of energy they produce for later use. Batteries may be just the solution. In California, there's now enough grid-scale battery storage to power millions of homes for a few hours. Battery pow ...  Show more

Why you'll probably be misdiagnosed in your lifetime

Nearly every person will experience at least one diagnostic error in their lifetime. That means either a delayed diagnosis, a wrong diagnosis – or no diagnosis at all. That’s according to a report by the National Academies of Sciences, Engineering and Medicine from 2015 on diagno ...  Show more

Recommended Episodes

Changing epilepsy care through entrepreneurship: Dr. Mark Cook
Sharp Waves: ILAE's epilepsy podcast

Send comments and feedback

People with epilepsy don't always know when they have had a seizure - and yet establishing seizure frequency is a key part of epilepsy managemen ...

  Show more

Episode 102: Pediatric Pulse Mini-Series: Inside the Epileptic Brain - How Myelin Plasticity Could Change Epilepsy Care
Stanford Medcast: Expert Voices in Medicine and Healthcare

Pediatric epilepsy is a complex condition that affects countless children, but advancements in treatment are paving the way for brighter futures. Join us as Dr. Juliet Knowles, Assistant Professor of Neurology at Stanford University, sheds light on the multifaceted nature of epil ...  Show more

Seizure Recurrence in Generalized Epilepsy After Switching Away From Valproate
Neurology® Podcast

Dr. Halley Alexander talks with Dr. Emanuele Cerulli Irelli about the research on seizure recurrence in women with idiopathic generalized epilepsy who switch from valproate to another medication. Read the related article in Neurology. This podcast is sponsored by argenx. Visit ww ...  Show more

Editing Cells Within the Body—a New CRISPR Frontier
I AM BIO

With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating pati ...  Show more